These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2831830)

  • 1. [Lyophilized combined live vaccine against swine fever and Aujeszky's disease].
    Wassiljew W; Simeonow I; Peschlejski P; Petkow P; Jotow M; Tatarow G; Dimitrow K
    Arch Exp Veterinarmed; 1987 Nov; 41(6):832-5. PubMed ID: 2831830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Simultaneous vaccination against Aujeszky's disease and European hog cholera].
    Bengelsdorff HJ; Becker W; Steinhoff H; Barth R
    Berl Munch Tierarztl Wochenschr; 1985 Apr; 98(4):109-12. PubMed ID: 2986592
    [No Abstract]   [Full Text] [Related]  

  • 3. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera.
    van Zijl M; Wensvoort G; de Kluyver E; Hulst M; van der Gulden H; Gielkens A; Berns A; Moormann R
    J Virol; 1991 May; 65(5):2761-5. PubMed ID: 1850051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
    Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
    Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the protective efficacy of recombinant pseudorabies viruses against pseudorabies and classical swine fever in pigs; influence of different promoters on gene expression and on protection.
    Hooft van Iddekinge BJ; de Wind N; Wensvoort G; Kimman TG; Gielkens AL; Moormann RJ
    Vaccine; 1996 Jan; 14(1):6-12. PubMed ID: 8821642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever.
    Peeters B; Bienkowska-Szewczyk K; Hulst M; Gielkens A; Kimman T
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3311-5. PubMed ID: 9400982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination of 'non-swine' against Aujeszky's disease].
    Akkermans JP
    Tijdschr Diergeneeskd; 1980 Dec; 105(24):1084-5. PubMed ID: 6255630
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunogenicity of an inactivated culture vaccine against Aujeszky's disease].
    Aĭrapetian VG; Khachatrian AB; Chobanian MS
    Veterinariia; 1978 Mar; (3):56-8. PubMed ID: 205992
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental studies in weaned pigs with three vaccines against Aujeszky's disease.
    McFerran JB; Dow C; McCracken RM
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):327-34. PubMed ID: 228904
    [No Abstract]   [Full Text] [Related]  

  • 11. [A field test of an associated vaccine for swine plague and Aujeszky's disease].
    Lysenko IP; Tsymbal AM; Kul'bachnaia MZ
    Veterinariia; 1967 May; 44(5):49-50. PubMed ID: 5629926
    [No Abstract]   [Full Text] [Related]  

  • 12. Formaldehyde-fixed cells infected with pseudorabies virus conferred resistance against Aujeszky's disease.
    Tanaka S; Imamura T; Matsui H; Sakaguchi M; Matsuo K; Yamamoto M
    J Vet Med Sci; 1994 Dec; 56(6):1177-9. PubMed ID: 7696414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of enzootic Aujeszky's disease on pig farms].
    Motovski A; Kurshelova R; Milachkov P; Georgiev Kh
    Vet Med Nauki; 1982; 19(3):22-8. PubMed ID: 6291224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trial of vaccination against Aujeszky's disease].
    Motovski A; Veselinova A; Dobrev V
    Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of dogs against pseudorabies (Aujeszky's disease), using an inactivated-virus vaccine.
    Pensaert MB; Commeyne S; Andries K
    Am J Vet Res; 1980 Dec; 41(12):2016-9. PubMed ID: 6259977
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aerogenic simultaneous vaccination of swine against plague, erysipelas and Aujeszky's disease].
    Khasanov ChG; Selivanov AV
    Veterinariia; 1976 Nov; (11):42-4. PubMed ID: 1035820
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenge experiments with the virus of Aujeszky's disease in non-vaccinated and vaccinated sheep.
    Rondhuis PR; Wirahadiredja RM; Akkermans JP; Jakubik J
    Zentralbl Veterinarmed B; 1978 Jan; 25(1):70-80. PubMed ID: 207055
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vaccination of piglets of different ages with inactivated Aujeszky's disease vaccine].
    Jakubik J; Wittmann G
    Berl Munch Tierarztl Wochenschr; 1979 Sep; 92(17):343-5. PubMed ID: 231429
    [No Abstract]   [Full Text] [Related]  

  • 19. Aujeszky's disease: vaccines and diagnostics.
    van Oirschot JT
    Vet Rec; 1988 Apr; 122(15):371. PubMed ID: 2837863
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant properties of propionibacterium avidum KP-40 in vaccination against endemic viral and bacterial infections. I. Swine immunized with live attenuated Aujeszky's disease virus vaccine and experimentally infected with virulent viruses.
    Markowska-Daniel I; Pejsak Z; Szmigielski S; Jeljaszewicz J; Pulverer G
    Zentralbl Bakteriol; 1992 Dec; 277(4):529-37. PubMed ID: 1338942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.